Recently, we reported that (i) casein kinase I (CK-I) specifically phosphorylates threonine residues on high mobility group protein 1 (HMG1) when incubated with cholesterol-3-sulfate (CH-3S); and (ii) CH-3S directly induces a drastic conformational change in HMG1.
; (ii) cdc-2-kinase phosphorylates HMG1, and this phosphorylation reduces its DNA-binding affinity in vitro 3) ; (iii) Chironomus HMG1 4) and mouse testis-specific HMG1 5) are phosphorylated by protein kinase C (PKC) and appear to be required for the functioning of DNA-binding proteins, including topoisomerase I-dependent supercoiling activities 5) ; and (iv) HMG1 in Drosophila embryos and in the cultured cells of Chironomus is phosphorylated by CK-II at multiple serine residues located within the acidic tails, and this phosphorylation is important for the proper functioning and turnover rates of HMG1. 6) However, the physiological significance of the phosphorylation of HMG1/2 by these protein kinases (CK-I, CK-II and PKC) in the regulation of inflammatory mediators is not clear in present.
Glycyrrhizin (GL) is present in large quantities in the roots and rhizomes of licorice, Glycyrrhiza glabra L., and is composed of a molecule of glycyrrhetinic acid (GA) and two molecules of glucuronic acid. We have been studying the physiological characteristics of the GL-binding proteins (gbPs) involved in inflammatory responses and the inhibitory effect of GL on gbP activities in vitro. [7] [8] [9] [10] [11] [12] Previously, we reported that (i) CK-II from mouse liver is selectively purified by GL-affinity column chromatography (HPLC) as a gbP 7) ; (ii) GL selectively inhibits the CK-II-mediated phosphorylation of cellular functional gbPs, such as glucocorticoid receptor, 7) lipoxygenase 3, 8) phospholipase A 2 (PLA 2 ) 9) and HIV-1 reverse transcriptase, 10, 11) in vitro; and (iii) a GA derivative (oGA) is a potent inhibitor at one tenth the concentration of GL to inhibit the CK-II-mediated phosphorylation of these gbPs, 11) and also inhibiting the PKC-mediated phosphorylation of lactoferrin-binding proteins (angiogenin-1 and lactogenin-like protein) in vitro. 12) To investigate the physiological correlation between GL, HMG1/2 and three protein kinases (CK-I, CK-II and PKC) in vitro, we set out to (i) characterize HMG1/2 from a 0.35 M NaCl extract of calf thymus as gbPs with substrate activities for these protein kinases; (ii) characterize GL, GA and oGA as potent inhibitors of the phosphorylation of HMG1/2 by these protein kinases in vitro; and (iii) determine the inhibitory effect of GL on the DNA-binding ability of HMG1 in vitro. GL-Affinity Column A GL-affinity column was prepared as originally described by Nakamura et al., 13) using Tresyl-5PW (packing gel for HPLC; Tosoh Mfg., Co., Ltd., Tokyo, Japan) and N-(glycyrrhizin)-30-a-lysine.
MATERIALS AND METHODS

Chemicals
Extraction of HMG1/2 from Calf Thymus HMG1/2 were purified from calf thymus according to a modified method described originally by Ogawa et al. 14) All procedures were performed at 0-4°C. Minced calf thymus (wet weight about 300 g) was homogenized in a power blender with six volumes of standard saline citrate (SSC: 0.14 M NaCl, 10 mM sodium citrate, pH 7.0), and then filtered through two layers of gauze. The filtrate was centrifuged at 2000ϫg for 15 min, and the sediment was then washed fivetimes with SSC in the same manner. The precipitates obtained were resuspended in 50 mM Tris-HCl (pH 7.6) containing 3 mM PMSF, then centrifuged at 6000ϫg for 10 min. , 25 mM phosphatidylserine, 3 mM 1,2-dioleoyl-rac-glycerol, PKC (approx. 10 ng) and the indicated doses of GL, GA or oGA. The [ 32 P]-labeled HMG1/2 in the reaction mixtures were detected by SDS-PAGE followed by autoradiography, as previously reported. 12) Phosphorylation of HMG1 by CK-I was carried out by incubating purified HMG1 with 20 mM [g-32 P]ATP in reaction mixtures comprising 40 mM Tris-HCl (pH 7.6), 2 mM dithiothreitol (DTT), 3 mM Mn 2ϩ , CK-I (approx. 20 ng) and 10 m M CH-3S (an activator of CK-I in HMG1). The mixtures were incubated for 30 min at 30°C with the indicated doses of GL, GA or oGA. After incubation, the [ 32 P]-labeled HMG1 (p31) in the reaction mixtures was detected by SDS-PAGE followed by autoradiography, as previously reported.
1)
Measurement of CD Spectra The far-UV CD spectra of purified HMG1/2 were obtained using a J-720 CD spectropolarimeter (JASCO). The spectra were measured at 25°C in the wavelength ranges of 210-260 nm at a recording rate of 50 nm/min using a 5 mm cell. The concentration of each HMG was approx. 70 ng/ml. The spectrum of each HMG is presented as the average of three repeat scans.
Gel Shift Assay To detect the HMG1-DNA fragment complex, a gel shift assay was performed according to a modified method described originally by Wisniewski and Schulze.
15) The 5Ј-end of the 27 bp DNA fragment (5Ј-TT-TAACTCGTACAAGAAAATATTTGAA-3Ј) was labeled by , 10% glycerol and 0.01 mg/ml poly (dI-dC) · poly (dI-dC)], and then incubated for 30 min at 30°C. After incubation, dye of 1/10 the volume of mixture was added to the reaction mixture to arrest the binding reaction. Aliquots (10 ml) of the mixture were applied to a 6% polyacrylamide gel containing TBE buffer [89 mM Tris, 89 mM boric acid and 2 mM EDTA (pH 8.0)]. After electrophoresis at 20 mA for 40 min, the gel was dried and the HMG1-32 P-labeled DNA fragment complexes on the gel were detected by exposing to a X-ray film.
RESULTS
Purification and Characterization of HMG1/2 as gbPs
To purify HMG1/2 in the 0.35 M NaCl crude extract of calf thymus, the extract (approx. 2.3 g protein) was applied onto a Mono P column and eluted with a linear gradient between 0.2 and 1.0 M NaCl (Fig. 1A) . Three major peaks (I, II and III) were detected. Peak I (p30, HMG2) was eluted between 0.5 and 0.6 M NaCl, whereas peak II (p31, HMG1) was eluted between 0.6 and 0.7 M NaCl, as reported previously. 1) SDS-PAGE detected a 30 kDa polypeptide (p30) in peak I and a 31 kDa polypeptide (p31) in peak II, respectively (Fig.  1B) .
To confirm HMG1/2 as gbPs, purified HMG1 (peak II, Fig. 1A ) and HMG2 fractions (peak I) were separately ap- plied to a GL-affinity column. They were each eluted with a linear NaCl gradient. p31 (HMG1) was eluted between 0.8 and 2.0 M NaCl from the GL-affinity column as a single polypeptide, whereas p30 (HMG2) was eluted between 0.6 and 1.7 M (Figs. 2A, 2B ). These results show that both HMG1/2 are gbPs.
GL-and GA-Induced Conformational Changes in HMG1/2 To obtain further confirmation for the direct binding of GL to HMG1/2, the CD spectra of HMG1 or HMG2 were determined after incubation for 10 min at room temperature with or without either GL or GA. It was found that a negative peak at 222 nm shifts in the positive direction after incubation of HMG1 or HMG2 with 100 mM GL or 100 mM GA. These shifts were significantly induced when HMG1 or HMG2 was incubated with GL rather than GA (Figs. 3A, 3B) . These results suggest that (i) the direct binding of GL or GA to HMG1/2 induces conformational changes of the proteins; and (ii) two molecules of glucuronic acid in the GL molecule may be implicated in an increase of the conformational changes in HMG1/2.
Effects of GL, GA and oGA on Phosphorylation of HMG1/2 by Protein Kinases in Vitro The effects of GL, GA and oGA on the phosphorylation of HMG1/2 by three protein kinases (PKC, CK-I and CK-II) were examined in vitro. As shown in Figs. 4A and 4B, it was found that (i) both HMG1/2 are phosphorylated by PKC in vitro; (ii) this phosphorylation is completely inhibited by 300 mM GA or 10 mM oGA; and (iii) the inhibition of this phosphorylation by GL requires a relatively much higher dose (ID 50 ϭapprox. 250 mM). There were no significant differences between the inhibitory effects of these three compounds on the PKC-mediated phosphorylation of these HMG1/2 in vitro.
As reported previously, 1) HMG1 (p31) was phosphorylated by CK-I in the presence of CH-3S in a dose-dependent manner (Fig. 5A) . Phosphorylation of HMG1 by CK-I was inhibited by GL (ID 50 ϭapprox. 50 mM) or GA (ID 50 ϭapprox. 30 mM) in a manner similar to that observed with the PKCmediated phosphorylation of HMG1/2 (Fig. 5A) . However, oGA at 1 mM stimulated the CK-I-mediated phosphorylation of HMG1 approx. 3-fold, but it was completely inhibited by 10 mM oGA (Fig. 5B) . The inhibitory effects of these three compounds on the CK-I-mediated phosphorylation of HMG2 were not determined, because HMG2 functioned as a poor substrate for CK-I in the presence of CH-3S. 1) However, no phosphorylation of HMG1/2 purified from calf thymus by CK-II was detected under our experimental conditions (data not shown).
These results show that (i) GA inhibits the phosphoryla-908 Vol. 24, No. 8
Fig. 2. Characterization of HMG1/2 as gbPs
HMG1/2 were further purified by GL-affinity column, previously equilibrated with 20 mM HEPES-NaOH (pH 7.6) containing 0.2 M NaCl. Elution was carried out with a linear gradient between 0.2 and 2.0 M NaCl at a flow rate of 1.0 ml/min, and 1.0 ml fractions were collected. Absorbance at 280 nm (Ϫ). Polypeptides in the indicated fractions were analyzed by SDS-PAGE. HMG1/2 on the gel were detected by silver staining. P, Mono P fraction.
[A] Purification of HMG1 (p31) in the Mono P peak II fraction; and [B] HMG2 (p30) in the Mono P peak I fraction. tion of HMG1/2 by two protein kinases (CK-I and PKC) in vitro; (ii) this phosphorylation is inhibited by oGA at one tenth the concentration of GL; and (iii) oGA at low doses (0.1-3 mM) stimulates significantly the CK-I-mediated phosphorylation of HMG1.
Inhibition of the DNA-Binding Ability of HMG1 by GL in Vitro Since GL induced a much larger conformational change in HMG1 than that observed with HMG2 (Fig. 3) , the DNA-binding ability of HMG1 was determined by a gel shift assay using a synthesized DNA fragment (5Ј-TTTAACTCG-TACAAGAAAATATTTGAA-3Ј) specific for HMG1. As shown in Fig. 6A, HMG1 binds to the DNA fragment in a dose-dependent manner, as reported by others. 16, 17) The effect P]ATP and 10 mM CH-3S in the presence of the indicated doses of GL, GA or oGA. The 32 P-labeled p31 in the reaction mixtures was detected by autoradiography after SDS-PAGE.
[B] The autoradiogram was scanned by a spectrophotometer. 100% represents the CK-I-mediated phosphorylation of HMG1 determined in the absence of these compounds. ᭹, GL; ᭺, GA; and ᭝, oGA.
Fig. 6. Effect of GL on the DNA-Binding Ability of HMG1 in Vitro
[A] The DNA-binding ability of purified HMG1 was determined by a gel shift assay using a synthesized DNA fragment (TTTAACTCGTACAAGAAAATATTTGAA). The 32 P-labeled DNA fragment was incubated for 30 min at 30°C with the indicated doses of HMG1. Free DNA and protein complexes formed with DNA were separated on 6% polyacrylamide gel. The gel was dried and exposed to a X-ray film. Lane 1, control (absence of HMG1); lane 2, 1.5 mg HMG1; lane 3, 3 mg HMG1; and lane 4, 6 mg HMG1. [B] 32 P-Labeled DNA fragment was incubated for 30 min at 30°C with purified HMG1 and the indicated doses of GL. Free DNA and protein complexes formed with 32 P-labeled DNA were separated on 6% polyacrylamide gel. The gel was dried and exposed to a X-ray film. of GL on the DNA-binding ability of HMG1 was determined after preincubation for 30 min at 30°C of HMG1 with the indicated doses of GL. Fig. 6B shows that GL at 30 mM inhibits completely the DNA-binding affinity of HMG1. A similar inhibition was also observed with HMG2 under the same experimental conditions (data not shown). These results suggest that (i) GL acts as an effective suppressor of the DNAbinding abilities of HMG1/2; and (ii) the GL-induced conformational changes in HMG1/2 may be implicated in the inhibition of the DNA-binding abilities of HMG1/2 by GL in vitro.
DISCUSSION
We found that (i) HMG1/2 purified from calf thymus are gbPs (Fig. 2); (ii) GL, as well as GA, induces conformational changes in HMG1/2 (Fig. 3) ; and (iii) GL inhibits the DNAbinding ability of HMG1 in a dose-dependent manner (Fig.  6C) . These results suggest that the direct binding of GL to HMG1/2 induces their conformational changes, which reduce their DNA-binding abilities in vitro. There is 80.4% homology between HMG1 (214 amino acid residues) and HMG2 (209 amino acid residues), which contain lysine-rich sequences in their HMG box domains A (positions and B (positions 94-162). 18, 19) It seems, therefore, that GL has a high affinity with HMG1/2, as has been demonstrated for histones (H2A and H2B) 20) and lactoferrin, 12) which have arginine-and lysine-rich domains. These characteristics of gbPs containing arginine-and lysine-rich domains are correlated closely with the observations that (i) GL has a high affinity with DNA-binding proteins, including HMG1/2 (Fig.  2) ; and (ii) GL induces a greater conformational change in HMG1/2 rather than GA (Fig. 3) . The latter observation suggests that two molecules of glucuronic acid in the GL molecule may be related to the increased conformational changes in HMG1/2.
We also found that phosphorylation of HMG1/2 by two protein kinases [PKC (Fig. 4) and CK-I (Fig. 5) ] is inhibited by GL, GA or oGA in a manner similar to their inhibitory effects observed in vitro with the CK-II-mediated phosphorylation of other gbPs, such as soybean lypoxygenase 3, 8) Habu snake phospholipase A 2 (PA2B), 9) HIV-1 enzymes (reverse transcriptase and protease) 11, 21) and 60S acidic ribosomal P proteins. 22) It seems likely that the GA moiety in the GL molecule may be responsible for the inhibition of the phosphorylation of the GL-binding functional proteins, including HMG1/2, by these three protein kinases (PKC, CK-I and CK-II) in vitro, because (i) phosphorylation of these gbPs by these protein kinases is more sensitive to GA rather than GL; and (ii) oGA (a GA derivative) effectively inhibits these protein phosphorylation in vitro.
Recently, Wang et al. 23, 24) have demonstrated that (i) the serum level of HMG1 increases after the administration of endotoxin, and injection of HMG1 itself is lethal; (ii) delayed administration of antibodies to HMG1 attenuates endotoxin lethality; and (iii) proinflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), induce the release of HMG1 from pituicytes in time-and dose-dependent manners. These reports suggest a possibility that HMG1 may participate in the physiological regulation of the inflammatory response as an inflammatory mediator. Our results presented here suggest that GL may neutralize the endotoxic effect of HMG1 by forming a complex with HMG1 in the serum during inflammation. The GL-induced inhibition of the physiological activities (phosphorylation and DNA-binding ability) of HMG1/2 may be involved in some of the antiinflammatory effects of GL in vivo. However, to explain clearly the biochemical mechanism involved in the anti-inflammatory effect of GL in vivo, it will be necessary to clarify the inhibitory effects of GL and GA on the phosphorylation of HMG1/2 by these protein kinases and their physiological effects on the DNA-binding activities of HMG1/2 at the cellular level.
It is well understood that steroid anti-inflammatory drugs selectively inhibit the expression of inflammation-induced enzymes [type II PLA 2 25) and cyclooxygenase 2 26) ], and also prevent the production of inflammatory cytokines (IL-1 and TNF) 27) during inflammatory responses. It seems, therefore, likely that GL may exert its anti-inflammatory effect in a manner similar to steroid anti-inflammatory drugs, because GL is a steroid-like molecule and directly binds to the glucocorticoid-like receptor 12) and arachidonate cascade related enzymes (LOX and PLA 2 ). 8, 9) In addition, our speculation that the GL-induced selective inhibition of the physiological activities of HMG1/2 may be involved in the anti-inflammatory effect of GL in vivo is strongly supported by indirect evidence that HMG1/2 enhance the sequence-specific DNA binding activities of specific receptors for steroid hormones (progesterone, estrogen, androgen and glucocorticoid), 28) and also stimulate the physiological activities of other transcriptional factors in the different physiological conditions. 29, 30) 
